Relx NV (ADR)  

(Public, NYSE:RENX)   Watch this stock  
Find more results for NYSE:ENL
18.15
+0.62 (3.54%)
Jul 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 18.08 - 18.22
52 week 14.84 - 18.22
Open 18.14
Vol / Avg. 136,692.00/166,539.00
Mkt cap 40.00B
P/E 29.00
Div/yield 0.32/2.48
EPS 0.63
Shares 985.00M
Beta 0.99
Inst. own 1%

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 14.90% 16.98%
Operating margin 25.27% 24.89%
EBITD margin - 33.29%
Return on average assets 8.26% 9.11%
Return on average equity 44.99% 47.44%
Employees 30,000 -
CDP Score - -

Address

Radarweg 29
AMSTERDAM, 1043 NX
Netherlands
+31-20-4852222 (Phone)
+31-20-4852032 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

RELX NV is a Netherlands-based company holding shares in RELX Group plc. RELX Group plc is a global provider of information and analytics for professional and business customers across industries. RELX Group plc serves customers in more than 180 countries. The Company operates in four market segments. Scientific, Technical & Medical helps customers advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity and improve outcomes. Risk & Business Analytics provides solutions and decision tools that combine public and industry-specific content with advanced technology and analytics. Legal is a provider of information and analytics to professionals in legal, corporate, government and non-profit organizations. Exhibitions organizes over 500 exhibitions a year, attracting more than seven million attendees. Shareholders in RELX NV own a 47.1% economic interest in RELX Group plc.

Officers and directors

Erik Engstrom Chief Executive Officer, Executive Director
Age: 52
Bio & Compensation  - Reuters
Nick L. Luff Chief Financial Officer, Executive Director
Age: 48
Bio & Compensation  - Reuters
Chet Burchett Chief Executive Officer Exhibitions
Bio & Compensation  - Reuters
Mark Kelsey Chief Executive Officer Risk Solutions and Business Information
Bio & Compensation  - Reuters
Ron Mobed Chief Executive Officer Scientific, Technical and Medical
Age: 56
Bio & Compensation  - Reuters
Mike Walsh Chief Executive Officer Legal
Bio & Compensation  - Reuters
Henry Adam Udow Chief Legal Officer and Company Secretary
Bio & Compensation  - Reuters
Wolfhart G. Hauser Senior Non-Executive Independent Director
Age: 66
Bio & Compensation  - Reuters
Ian Fraser Human Resources Director
Bio & Compensation  - Reuters
Kumsal Bayazit Chief Strategy Officer
Bio & Compensation  - Reuters